![]() |
市場調查報告書
商品編碼
1416189
神經技術設備市場- 按產品類型(神經刺激、神經假體、神經感測、神經復健)、病症(癲癇、帕金森氏症、認知障礙)、最終用途(醫院、ASC、家庭護理設施) - 全球預測,2023-2032 年Neurotech Devices Market - By Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation), Conditions (Epilepsy, Parkinsons Disease, Cognitive Disorder), End-use (Hospital, ASC, Homecare Facility)- Global Forecast, 2023-2032 |
在技術進步、神經系統疾病盛行率增加和人口老化的推動下,全球神經技術設備市場預計 2023 年至 2032 年CAGR將達到 13.8%。
根據世界衛生組織 2023 年的報告,神經系統疾病是全球第二大死因,每年導致 900 萬人死亡,是導致殘疾調整生命年的主要原因。隨著人口老化的加劇和慢性神經系統疾病的增加,對創新和高效的神經技術解決方案的需求不斷增加。此外,研發的快速步伐,特別是神經影像和神經調節技術的研發,正在推動市場向前發展。
整個神經技術設備市場根據產品、狀況、創新、最終用途和地區進行分類。
在神經假體技術進步和醫療保健提供者意識不斷提高的推動下,神經假體細分市場預計到 2032 年將實現良好成長。這些設備旨在透過直接與神經系統連接來恢復喪失的功能或補償殘疾。專注於開發更複雜和方便用戶使用的神經假體有望進一步開闢新的成長領域。
在慢性疼痛盛行率不斷上升和神經技術設備有效性的推動下,疼痛管理預計將在 2023 年至 2032 年期間穩步成長。這些設備,包括神經調節器和神經刺激器,正在成為治療疼痛的有效解決方案。它們調節神經活動,緩解神經性疼痛或偏頭痛等疾病的患者。人們對非侵入性和無藥物疼痛管理方案的認知不斷增強,正在促進產品的採用。
在人口老化、醫療保健支出增加以及對神經系統疾病認知不斷提高的推動下,亞太地區神經技術設備市場預計到 2032 年將出現強勁成長。該地區各國政府和醫療保健組織正在投資基礎設施和研究計劃,以支援神經技術設備的開發和採用。不斷的技術進步和合作將在未來幾年促進亞太地區市場的成長。
The global neurotech devices market is expected to witness a CAGR of 13.8% during 2023 and 2032, driven by technological advancements, increasing prevalence of neurological disorders, and ageing population.
According to a report by WHO in 2023, neurological disorders, the second leading global cause of death account for a staggering 9 million annual deaths and are the leading contributors to disability-adjusted life years. With a growing aging population and a rise in chronic neurological conditions, there is an escalating demand for innovative and efficient neurotech solutions. Additionally, the rapid pace of R&D, particularly in neuroimaging and neuromodulation technologies, is propelling the market forward.
The overall neurotech devices market is classified based on product, condition, innovation, end-use, and region.
The neuroprostheses segment is set for decent growth through 2032, driven by advancements in neuroprostheses technology and growing awareness among healthcare providers. These devices are designed to restore lost functions or compensate for disabilities by interfacing directly with the nervous system. The focus on developing more sophisticated and user-friendly neuroprostheses is further expected to open new arenas for growth.
Pain management is expected to witness steady growth during 2023-2032, driven by increasing prevalence of chronic pain conditions and effectiveness of neurotech devices. These devices, including neuromodulators and neurostimulators, are emerging as effective solutions for managing pain. They modulate neural activity, offering relief to patients suffering from conditions such as neuropathic pain or migraines. The growing awareness of non-invasive and drug-free pain management options is fostering the product adoption.
Asia Pacific neurotech devices market is anticipated to witness robust growth through 2032 driven by aging population, increasing healthcare expenditures, and rising awareness about neurological disorders. Governments and healthcare organizations in the nations across the region are investing in infrastructure and research initiatives to support the development and adoption of neurotech devices. The constant technological advancements and collaborations will augment the APAC market growth in the coming years.